Hear Dr Lipham discus Controversies in GERD
Gastroesophageal Reflux Disease ( GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life.
Join us for the next live presentation and discussion on Controversies in Gastroesophageal Reflux Disease. This interactive presentation will cover long term PPI therapy, endoscopic management of GERD and when to consider surgery. This virtual presentation will take place on Wednesday, December 16 from 13:30 –15:00 GMT.
- 08:30 EST New York
- 13:30 GMT
- 14:30 CET Amsterdam
- 22:30 JST Tokyo
Click HERE to register